Medical Marijuana, Inc.’s HempMeds Brasil™ Now Has Three Medical Indications Approved as Prescriptions – 100% of the Costs Now Covered by Brazilian Government
December 14, 2015 09:00 ET
|
Medical Marijuana Inc
SAN DIEGO, Dec. 14, 2015 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc.’s (OTC Pink:MJNA) cannabidiol (CBD) hemp oil – a legal U.S. cannabis product shipping to all 50 states – is creating global...
NATIONAL DISABILITY INSTITUTE AND ACORDA THERAPEUTICS EXPAND FINANCIAL WELLNESS PROGRAM TO REACH MORE PEOPLE
December 02, 2015 11:35 ET
|
National Disability Institute
WASHINGTON, Dec. 2, 2015 (GLOBE NEWSWIRE) -- On December 9th, National Disability Institute (NDI) will launch the fifth annual Financial Wellness Program, designed to help people living with...
Raptor Pharmaceutical Corp. Expands Rare Disease Portfolio With the Acquisition of Quinsair(TM)
August 20, 2015 17:16 ET
|
Raptor Pharmaceutical Inc
First Inhaled Fluoroquinolone Therapy for Patients with Cystic Fibrosis
Approval Received in the European Union and Canada
Expansion of Pipeline with Multiple Late-Stage Orphan Indication...
Raptor Pharmaceutical Receives FDA Approval of Expanded Label for PROCYSBI(R) to Treat Children Aged 2-6 Years With Nephropathic Cystinosis
August 17, 2015 07:05 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Aug. 17, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (NASDAQ:RPTP) today announced that the U.S. Food and Drug Administration (FDA) approved the expanded use of PROCYSBI®...
Raptor Pharmaceutical to Hold Second Quarter 2015 Financial Results Conference Call and Webcast on Thursday, August 6, 2015, at 4:30 p.m. EDT
July 30, 2015 07:30 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., July 30, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the company will release second quarter 2015 financial results on Thursday, August 6,...
Raptor Pharmaceutical Announces Management Changes
July 15, 2015 07:30 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., July 15, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced the appointment of Ashley Gould, J.D. as its Senior Vice President, General Counsel and...
Raptor Pharmaceutical to Hold First Quarter 2015 Financial Results Conference Call and Webcast on Thursday, May 7, 2015 at 4:30 p.m. EDT
April 30, 2015 07:30 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the company will release first quarter 2015 financial results on Thursday, May 7, 2015...
DiamiR Announces Poster Presentation at the Clinical Trials on Alzheimer's Disease 2014
November 17, 2014 08:02 ET
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - November 17, 2014) - DiamiR Biosciences, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the company's...
DiamiR Announces Publication and Discusses Merits of Universal Screening Test Based on Organ-Enriched microRNA Signatures
November 03, 2014 08:02 ET
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - November 03, 2014) - DiamiR Biosciences Corp., a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today the...
DiamiR Announces Corporate Presentation at Life Sciences Summit 2014
October 22, 2014 08:02 ET
|
DiamiR LLC
MONMOUTH JUNCTION, NJ--(Marketwired - October 22, 2014) - DiamiR Biosciences, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the company's...